Efficacy of Resveratrol in Depression

Summary

Patients with depression (target number - 60) receive resveratrol 500 mg or placebo (1:1) each morning daily for 1 month with primary outcome measures of the score change on depression rating scale HDRS-17 and change in SIRT1 activity in the blood measured 4 times over the study period (before, in the middle, after the intervention, and in 2 week follow up).

Timeline

Start

2018-07-04

Primary completion

2019-08-27

Completion

2019-09-18

Drugs

Indications